Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis.
about
Niacin for primary and secondary prevention of cardiovascular events.Cholesteryl ester transfer protein: ace of spades, queen of hearts, or the joker?Cholesteryl ester transfer protein (CETP) I405V polymorphism and cardiovascular disease in eastern European Caucasians - a cross-sectional studyThe cardiovascular risk reduction benefits of a low-carbohydrate diet outweigh the potential increase in LDL-cholesterol.
P2860
Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical benefit from pharmaco ...... rol: meta-regression analysis.
@en
type
label
Clinical benefit from pharmaco ...... rol: meta-regression analysis.
@en
prefLabel
Clinical benefit from pharmaco ...... rol: meta-regression analysis.
@en
P2093
P2860
P1433
P1476
Clinical benefit from pharmaco ...... rol: meta-regression analysis.
@en
P2093
F Hourcade-Potelleret
P Mismetti
Renée Benghozi
U Torriani
P2860
P304
P356
10.1136/HEARTJNL-2014-306691
P407
P577
2015-04-14T00:00:00Z